Alleged to be the next innovation in blood thinners, Xarelto (rivaroxaban) is marketed heavily as a blood thinner that does not require daily blood monitoring and the meal restrictions of Warfarin/Coumadin or Heparin.

Blood thinners are used to reduce blood clots in order to prevent serious injury. Xarelto is marketed for two primary situations:

  1. For use in patients who are scheduled to undergo hip or knee replacement surgery to prevent or treat the formation of blood clots (Deep Vein Thrombosis or Pulmonary Embolism); or
  2. To minimize the risk of stroke in patients with nonvalvular atrial fibrillation.

Unfortunately, Xarelto may result in uncontrollable bleeding. Unlike previous blood thinners, Xarelto does not have an antidote and once bleeding starts it may be difficult to stop. Life threatening side effects that may be linked to Xarelto use:

  • Gastrointestinal bleeding;
  • Brain hemorrhaging;
  • Uncontrolled wound bleeding;
  • Stroke;
  • Pulmonary Embolism; and
  • Thrombosis.

It is alleged that Xarelto’s manufacturers knew of its dangerous side effects and failed to properly warn of these hazards. Without this knowledge, many patients chose to take Xarelto not knowing the true risk. If you think you or a loved one has been injured by Xarelto, contact Cole | Reichek.